Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleCertolizumab pegol plus MTX administered every 4 weeks is effective in patients with RA who are partial responders to MTX.AuthorsChoy, Ernest; McKenna, Frank; Vencovsky, Jiri; Valente, Robert; Goel, Niti; VanLunen, Brenda; Davies, Owen; Stahl, Hans-Detlev; Alten, RiekePublicationRheumatology, 2012, Vol 51, Issue 7, p1226ISSN1462-0324Publication typeJournal Article